Table 2 Spearman correlations between betatrophin levels and T2D risk factors.

From: Higher plasma betatrophin/ANGPTL8 level in Type 2 Diabetes subjects does not correlate with blood glucose or insulin resistance

Variables

Non-diabetic

T2D

ρ

P -value

ρ

P -value

Age (years)

0.49

<0.0001

0.46

<0.0001

BMI (kg/m2)

0.14

<0.0001

−0.04

0.3931

Waist/hip ratio

0.16

<0.0001

0.18

<0.0001

FBG (mmol/L)

0.19

<0.0001

−0.04

0.3162

HbA1C, %

0.14

<0.0001

0.02

0.6140

Insulin (mU/L)

0.14

<0.0001

−0.02

0.6680

HOMA-IR

0.17

<0.0001

−0.03

0.4776

HOMA-β

0.05

0.1526

0.01

0.7070

Total cholesterol (mmol/L)

0.05

0.0845

−0.25

<0.0001

Triglycerides (mmol/L)

0.15

<0.0001

−0.02

0.5714

HDL cholesterol (mmol/L)

−0.03

0.3995

0.001

0.9819

LDL cholesterol (mmol/L)

0.02

0.5426

−0.27

<0.0001

Diabetes duration (years)

-

-

0.29

<0.0001

  1. BMI, FBG, T2D: fasting blood glucose ≥7 mmol/l, under treatment, or self-reported of previously diagnosed T2D. Duration of T2D was calculated for subjects with diabetes. Partial Spearman correlation coefficients were adjusted for age, gender and ethnicity.